Medicine and HealthNature Chemical Biology
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
L. Zhang, S. Dutta, et al.
Discover groundbreaking research by Lianghui Zhang and colleagues at the University of Illinois, showing how engineered soluble ACE2 proteins can prevent lung injury and enhance survival against multiple SARS-CoV-2 variants. This innovative study offers hope for developing new therapeutics in the fight against COVID-19.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
An engineered ACE2 decoy neutralizes SARS-CoV-2 Omicron BA.5 in vitro and in vivo
H. B., L. G. W., et al.
Medicine and Health
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
X. Chi, Y. Guo, et al.
Medicine and Health
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
D. Sun, Z. Sang, et al.
Medicine and Health
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
M. C. Miranda, E. Kepl, et al.
